- Home
- SRPT vs SEIC Comparison
SRPT vs SEIC Comparison
Compare SRPT & SEIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRPT
- SEIC
- Stock Information
- Founded
- SRPT 1980
- SEIC 1968
- Country
- SRPT United States
- SEIC United States
- Employees
- SRPT N/A
- SEIC N/A
- Industry
- SRPT Biotechnology: Pharmaceutical Preparations
- SEIC Investment Bankers/Brokers/Service
- Sector
- SRPT Health Care
- SEIC Finance
- Exchange
- SRPT Nasdaq
- SEIC Nasdaq
- Market Cap
- SRPT 12.2B
- SEIC 10.4B
- IPO Year
- SRPT 1997
- SEIC N/A
- Fundamental
- Price
- SRPT $104.54
- SEIC $80.23
- Analyst Decision
- SRPT Strong Buy
- SEIC Hold
- Analyst Count
- SRPT 21
- SEIC 5
- Target Price
- SRPT $182.00
- SEIC $75.20
- AVG Volume (30 Days)
- SRPT 1.0M
- SEIC 791.1K
- Earning Date
- SRPT 11-06-2024
- SEIC 10-23-2024
- Dividend Yield
- SRPT N/A
- SEIC 1.15%
- EPS Growth
- SRPT N/A
- SEIC 23.19
- EPS
- SRPT 1.22
- SEIC 4.15
- Revenue
- SRPT $1,640,348,000.00
- SEIC $2,052,819,000.00
- Revenue This Year
- SRPT $45.98
- SEIC $13.09
- Revenue Next Year
- SRPT $78.13
- SEIC $7.60
- P/E Ratio
- SRPT $85.70
- SEIC $19.33
- Revenue Growth
- SRPT 48.45
- SEIC 8.53
- 52 Week Low
- SRPT $78.67
- SEIC $57.43
- 52 Week High
- SRPT $173.25
- SEIC $81.97
- Technical
- Relative Strength Index (RSI)
- SRPT 23.65
- SEIC 67.99
- Support Level
- SRPT $116.32
- SEIC $74.42
- Resistance Level
- SRPT $122.63
- SEIC $81.97
- Average True Range (ATR)
- SRPT 4.97
- SEIC 1.27
- MACD
- SRPT -2.19
- SEIC 0.19
- Stochastic Oscillator
- SRPT 6.47
- SEIC 76.95
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of company's product candidates are at an early stage of development.
About SEIC SEI Investments Company
SEI Investments provides investment processing, management, and operations services to financial institutions, asset managers, asset owners, and financial advisors in four material segments: private banks, investment advisors, institutional investors, and investment managers. SEI also has a minority interest in LSV Asset Management, a value equity asset manager with about $99 billion in assets under management. As of December 2023, SEI (including LSV) manages, administers, or advises about $1.4 trillion in assets.